From www.bloodjournal.org by guest on September 29, 2016. For personal use only.
Errata
Teachey DT, Rheingold SR, Maude SL, et al. Cytokine release syndrome after
blinatumomab treatment related to abnormal macrophage activation and ameliorated with
cytokine-directed therapy. Blood. 2013;121(26):5154-5157.
On page 5156 of the 27 June 2013 issue, the Acknowledgments section is missing. The Acknowledgment should have read, “This work was
supported with funding from the Pennsylvania Department of Health (S.A.G.).” The error has been corrected in the online version, which now
differs from the print version.
DOI 10.1182/blood-2016-07-730671
© 2016 by The American Society of Hematology
Maude SL, Teachey DT, Porter DL, Grupp SA. CD19-targeted chimeric antigen receptor
T-cell therapy for acute lymphoblastic leukemia. Blood. 2015;125(26):4017-4023.
In the Acknowledgments section on page 4022 of the 25 June 2015 issue, funding from the Pennsylvania Department of Health is not
mentioned. The error has been corrected in the online version, which now differs from the print version.
DOI 10.1182/blood-2016-07-730333
© 2016 by The American Society of Hematology
Qin H, Cho M, Haso W, et al. Eradication of B-ALL using chimeric antigen
receptor–expressing T cells targeting the TSLPR oncoprotein. Blood. 2015;126(5):629-639.
In the Acknowledgments section on page 638 of the 30 July 2015 issue, funding from the Pennsylvania Department of Health is not
mentioned. The error has been corrected in the online version, which now differs from the print version.
DOI 10.1182/blood-2016-07-730697
Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease:
how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126.
On page 3124 in the 23 June 2016 issue, reference 20 cites the incorrect source. It should read “Furlan SN, Watkins B, Tkachev V, et al.
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. Sci Transl Med. 2015;7(315):
315ra191.” The error has been corrected in the online version, which now differs from the print version.
DOI 10.1182/blood-2016-07-730580
© 2016 by The American Society of Hematology
BLOOD, 8 SEPTEMBER 2016 x VOLUME 128, NUMBER 10
1441
From www.bloodjournal.org by guest on September 29, 2016. For personal use only.
2016 128: 1441
doi:10.1182/blood-2016-07-730697
Qin H, Cho M, Haso W, et al. Eradication of B-ALL using chimeric
antigen receptor−expressing T cells targeting the TSLPR oncoprotein.
Blood. 2015;126(5):629-639.
Updated information and services can be found at:
http://www.bloodjournal.org/content/128/10/1441.3.full.html
Articles on similar topics can be found in the following Blood collections
Free Research Articles (4070 articles)
Information about reproducing this article in parts or in its entirety may be found online at:
http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests
Information about ordering reprints may be found online at:
http://www.bloodjournal.org/site/misc/rights.xhtml#reprints
Information about subscriptions and ASH membership may be found online at:
http://www.bloodjournal.org/site/subscriptions/index.xhtml
Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society
of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036.
Copyright 2011 by The American Society of Hematology; all rights reserved.